Penicillamine (D-(-)-Penicillamine) (5 mg; 7 d; CD4 and CD splenocytes) promotes cellular immune responses.Medlife has not independently confirmed the accuracy of these methods. They are for reference only.ass="cpd-vitro-list">
Western Blot Analysis-vv-tbl">
Penicillamine (D-(-)-Penicillamine) (200 mg/kg; i.g.; daily, for 3, 10 and 14 d; tx mice and DL mice) increases serum free copper concentration.Penicillamine (200 mg/kg; i.g.; daily, for 3, 10 and 14 d; tx mice and DL mice) increases ATP7A and CTR1 mRNA expression in the brain of tx mice.Penicillamine (200 mg/kg; i.g.; daily, for 3, 10 and 14 d; tx mice and DL mice) induces oxidative-stress in the central nervous system.Penicillamine (0.1-250 mg/kg; i.p.; once, for 90 min; male NMRI mice) has binaural phase effect on seizure.Penicillamine (5 mg/kg; i.v.; daily, for 8 weeks; male BN rats) prevents the onset of autoimmunity at a low dose.Medlife has not independently confirmed the accuracy of these methods. They are for reference only.
|
运输条件 |
Room temperature or refrigerated transport.
|
储存方式 |
Powder; -20°C; 3 years; 4°C; 2 years;
|
ClinicalTrial |
|
结构分类 |
Ketones, Aldehydes, Acids
|